COVID-19 and cardiovascular complications – preliminary results of the LATE-COVID study
Joanna Lewek,Joanna Lewek,Izabela Jatczak-Pawlik,Izabela Jatczak-Pawlik,Marek Maciejewski,Piotr Jankowski,Maciej Banach,Maciej Banach,Maciej Banach +8 more
Reads0
Chats0
TLDR
Diabetes, elevated level of CRP and troponin, heart rate variability parameters and worsening of left ventricular ejection fraction are related to the severity of cardiovascular complications following COVID-19 infection.Abstract:
Introduction: Coronavirus disease 2019 (COVID-19) may affect many organs and may be responsible for numerous complications including cardiovascular problems Methods: We analysed consecutive patients (n = 51) admitted to the cardiology department between 1st October 2020 and 31st January 2021 due to symptoms which might have reflected cardiovascular complications following COVID-19 We collected data concerning clinical characteristics, results of laboratory tests, echocardiography and 24-hour ambulatory ECG recording Results: The post-COVID-19 complications appeared 1–4 months after disease recovery Severe cardiovascular complications were observed in 27 5% of hospitalized patients In comparison to those with mild complications, patients with severe complications had significantly higher prevalence of diabetes (36 vs 8%;p = 0 01), decrease in ejection fraction (36% vs 0%, p < 0 001), higher resting heart rate at admission (85 vs 72 bpm;p < 0 001), and higher levels of C-reactive protein (p = 0 02) and troponin T (17 9 vs 4 2 pg/ml;p = 0 01) Dyspnoea and exercise intolerance were also more frequent in patients with severe complications Conclusions: Diabetes, elevated level of CRP and troponin, heart rate variability parameters and worsening of left ventricular ejection fraction are related to the severity of cardiovascular complications following COVID-19 infection [ABSTRACT FROM AUTHOR] Copyright of Archives of Medical Science is the property of Termedia Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission However, users may print, download, or email articles for individual use This abstract may be abridged No warranty is given about the accuracy of the copy Users should refer to the original published version of the material for the full abstract (Copyright applies to all Abstracts )read more
Citations
More filters
Journal ArticleDOI
ESCMID rapid guidelines for assessment and management of long COVID
Dana Yelin,Charalampos D. Moschopoulos,Ili Margalit,Effrossyni Gkrania-Klotsas,Francesco Landi,Jean-Paul Stahl,Dafna Yahav +6 more
TL;DR: In this paper , the authors provide evidence-based recommendations for the assessment and management of individuals with persistent symptoms after acute COVID-19 infection and to provide a definition for this entity, termed "long COVID".
Journal ArticleDOI
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
Mariann Gyöngyösi,Pilar Alcaide,Folkert W. Asselbergs,Bianca J. J. M. Brundel,Giovanni G. Camici,Paula A. da Costa Martins,Péter Ferdinandy,Marianna Fontana,Henrique Girão,Massimiliano Gnecchi,Can Gollmann-Tepeköylü,Petra Kleinbongard,Thomas Krieg,Rosalinda Madonna,M. Paillard,Antonis Pantazis,R. Perrino,Maurizio Pesce,Gabriele G. Schiattarella,Joost P.G. Sluijter,Sabine Steffens,Carsten Tschöpe,Sophie Van Linthout,Sean M. Davidson +23 more
TL;DR: In this article , the authors aim to provide insight into the possible causes and therapeutic options available for the cardiovascular manifestations of long COVID, including chronic fatigue, chest pain, ECG abnormalities, postural orthostatic tachycardia, or newly developed supraventricular or ventricular arrhythmias.
Journal ArticleDOI
Evolution of Echocardiographic Abnormalities Identified in Previously Healthy Individuals Recovering from COVID-19
Cristina Tudoran,Mariana Tudoran,Talida Georgiana Cut,Voichita Lazureanu,Cristian Oancea,Adelina Raluca Marinescu,S. Pescariu,Gheorghe Pop,Felix Bende +8 more
TL;DR: In patients with post-acute COVID-19 syndrome, several cardiac abnormalities may be assessed by TTE, most of them alleviating in time, raising the presumption of chronic alterations.
Journal ArticleDOI
Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID
Yoon-Joo Kim,Seong Eun Kim,Tark Kim,Ki Wook Yun,So Hee Lee,Eun No Lee,Jun-Won Seo,Young Hee Jung,Yong Pil Chong +8 more
TL;DR: Advice on diagnosis and management based on the latest updated available evidence and the consensus of expert opinion is provided, including appropriate interventions for long COVID that can be used in clinical practice.
Journal ArticleDOI
Protective role of nutraceuticals against myocarditis
Don Handelman,Jernej Weiss +1 more
TL;DR: In this article , the properties of phytochemicals as plant-derived active ingredients which can be used in the prevention and treatment of myocarditis and its associated risk factors are described.
References
More filters
Journal ArticleDOI
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
Alan John Camm,Marek Malik,J. T. Bigger,G. Breithardt,Sergio Cerutti,Richard J. Cohen,Philippe Coumel,Ernest L. Fallen,H.L. Kennedy,Robert E. Kleiger,Federico Lombardi,Alberto Malliani,Arthur J. Moss,Jeffrey N. Rottman,Georg Schmidt,Peter J. Schwartz,D.H. Singer +16 more
Journal ArticleDOI
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.
TL;DR: Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the COVID-19, which can aggravate the damage to the heart.
Journal ArticleDOI
Cardiovascular complications in COVID-19.
TL;DR: Emergency clinicians should be aware of these cardiovascular complications when evaluating and managing the patient with COVID-19 and current therapies for CO VID-19 may interact with cardiovascular medications.
Journal ArticleDOI
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.
TL;DR: DM was associated with mortality, severe COVID-19, ARDS, and disease progression in patients with CO VID-19 and the association was weaker in studies with median age ≥55 years-old compared to <55 years old, and in prevalence of hypertension ≥25% compared to<25%.
Journal ArticleDOI
Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
Sonu Bhaskar,Sonu Bhaskar,Akansha Sinha,Maciej Banach,Shikha Mittoo,Robert Weissert,Joseph S. Kass,Santhosh Rajagopal,Anupama R. Pai,Shelby Kutty +9 more
TL;DR: An overview of the cytokine storm and its implications in COVID-19 settings is presented and potential pathways or biomarkers that could be targeted for therapy are identified.